Raymond James Financial’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.92M Sell
125,278
-348
-0.3% -$12.4K ﹤0.01% 2963
2026
Q2
$5.17M Buy
125,626
+42,639
+51% +$1.61M ﹤0.01% 2709
2026
Q1
$2.97M Buy
82,987
+371
+0.4% +$13.5K ﹤0.01% 3034
2025
Q4
$2.68M Sell
82,616
-1,407
-2% -$43.9K ﹤0.01% 3039
2025
Q3
$2.37M Buy
84,023
+5,710
+7% +$164K ﹤0.01% 3047
2025
Q2
$2.36M Buy
78,313
+16,407
+27% +$556K ﹤0.01% 2943
2025
Q1
$2.53M Buy
61,906
+32,212
+108% +$1.55M ﹤0.01% 2829
2024
Q4
$1.61M Buy
+29,694
New +$1.7M ﹤0.01% 3127

Other funds holding CRI

Raymond James Financial's CRI Position: Q3 2026 in Review

Raymond James Financial reduced its Carter's (CRI) stake by 0.28% in Q3 2026, selling an estimated $12.4K and leaving 125,278 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Raymond James Financial first reported a position in CRI in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.17M in Q2 2026. 295 funds tracked by Wall St. Rank hold CRI as of Q3 2026.

  • Raymond James Financial held 125,278 shares of Carter's worth $3.92M as of Q3 2026.
  • Raymond James Financial sold 348 Carter's shares in Q3 2026, an estimated $12.4K.
  • Carter's made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2963 holding.
  • Raymond James Financial first reported a position in Carter's in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Carter's position peaked at $5.17M in Q2 2026.
  • 295 funds tracked by Wall St. Rank held Carter's as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.